Exercise test is essential in LV-only fusion CRT pacing without right ventricle lead

References

• Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group; ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw12827206819
   PubMed Web of Science ®Google Scholar
• Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(29):2281–2329.23801822
   PubMed Web of Science ®Google Scholar
• Burri H, Prinzen FW, Gasparini M, et al. Left univentricular pacing for cardiac resynchronization therapy. Europace. 2017;19(6):912–919.28339579
   PubMed Web of Science ®Google Scholar
• Gasparini M, Bocchiardo M, Lunati M, et al. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patiens with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J. 2006;152(1):155.e1–155.e7.
   Web of Science ®Google Scholar
• Boriani G, Kraning W, Donal E, et al. A randomized double blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD back-up in Heart Failure Patients (BLEFT HF) trial. Am Heart J. 2010;159(6):1052–1058.e1.20569719
   PubMed Web of Science ®Google Scholar
• Martin DO, Lemke B, Birnie D, et al. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012;9(11):1807–1814.22796472
   PubMed Web of Science ®Google Scholar
• Cozma D, Vacarescu C, Petrescu L, et al. CRT pacing: midterm follow-up in LV only pacing without RV lead in patients with normal AV conduction. J Clin Med. 2018;7(12):531.
   Web of Science ®Google Scholar
• Bertini M, Delgado V, Bax JJ, et al. Why, how and when do we need to optimize the setting of cardiac resynchronization therapy? Europace. 2009;11:v46–v57.19861391
   PubMed Web of Science ®Google Scholar
• Chousou PA, Pugh PJ. How to deliver optimal cardiac resynchronisation therapy. Heart. 2018;104:1300–1307.29217631
   PubMed Web of Science ®Google Scholar
• Grimaldi A, Gorodeski EZ, Rickard J. Optimizing cardiac resynchronization therapy: an update on new insights and advancements. Curr Heart Fail Rep. 2018;15(3):156–160. doi:10.1007/s11897-018-0391-y29667071
   PubMedGoogle Scholar
• Cozma D, Kalifa J, Pescariu S, et al. Can simple doppler measurements estimate interatrial conduction time? Pacing Clin Electrophysiol. 2003;26(1P2):436–439.12687861
   PubMed Web of Science ®Google Scholar
• Gianfranchi L, Bettiol K, Sassone B, et al. Fusion beat in patients with heart failure treated with left ventricular pacing: may ECG morphology relate to mechanical synchrony? A pilot study. Cardiovasc Ultrasound. 2008;6:1. doi:10.1186/1476-7120-6-118167164
   PubMed Web of Science ®Google Scholar
• Cohen-Solal A, Jacobson FA, Piña LI. Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance. ESC Heart Fail. 2017;4(4):499–506. doi:10.1002/ehf2.1215329154422
   PubMed Web of Science ®Google Scholar
• de Riva-Silva M, López Gil M, Fontenla-Cerezuela A, et al. Usefulness of exercise test in cardiac resynchronization therapy follow-up. Rev Esp Cardiol. 2013;66:912–913. doi:10.1016/j.rec.2013.05.02124774003
   PubMed Web of Science ®Google Scholar
• Valzania C, Eriksson MJ, Boriani G, et al. Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods. Europace. 2008;10(10):1161–1169. doi:10.1093/europace/eun21618753213
   PubMed Web of Science ®Google Scholar
• Leclercq C. Problems and troubleshooting in regular follow-up of patients with cardiac resynchronization therapy. Europace. 2009;11:v66–v71. doi:10.1093/europace/eup12419861393
   PubMed Web of Science ®Google Scholar
• Lee JU, Kim KS, Kim JH, et al. PR interval behavior during exercise stress test. Korean J Intern Med. 1995;10(2):137–142.7495772
   PubMedGoogle Scholar
• Luceri RM, Brownstein SL, Vardeman L, et al. PR interval behavior during exercise: implications for physiological pacemakers. Pacing Clin Electrophysiol. 1990;13(12 Pt 2):1719–1723.1704529
   PubMed Web of Science ®Google Scholar
• Vatasescu R, Berruezo A, Mont L, et al. Midterm ‘super-response‘ to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mapping. Europace. 2009;11(12):1675–1682. doi:10.1093/europace/eup33319880850
   PubMed Web of Science ®Google Scholar
• Guo T, Li R, Zhang L, et al. Biventricular pacing with ventricular fusion by intrinsic activation in cardiac resynchronization therapy. Int Heart J. 2015;56(3):293–297.25912899
   PubMed Web of Science ®Google Scholar
• Thibault B, Ducharme A, Harel F, et al. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation. 2011;124(25):2874–2881.22104549
   PubMed Web of Science ®Google Scholar
• Biffi M, Bertini M, Ziacchi M, et al. Left ventricular pacing by automatic capture verification. Europace. 2007;9:1177–1781.17932022
   PubMed Web of Science ®Google Scholar
• Ghosh S, Stadler RW, Mittal S. Automated detection of effective left-ventricular pacing: going beyond percentage pacing counters. Europace. 2015;17(10):1555–1562.25862307
   PubMed Web of Science ®Google Scholar
• Hidalgo FJ, Carrasco F, Castillo JC, et al. Early Therapy with Beta Blockers Plus Ivabradine Versus Beta Blockers Alone in Patients Hospitalised with Heart Failure and Reduced Ejection Fraction (ETHIC-AHF Study): results at one-year follow-up. Int J Clin Cardiol. 2017;93:093.
   Google Scholar
• Crişan S, Petrescu L, Lazăr MA, et al. Reduced ejection fraction heart failure–new data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments. Clin Interv Aging. 2018;13:651–656.29713149
   PubMed Web of Science ®Google Scholar
• Massoullié G, Chouki C, Mulliez A, et al. Effect of optimization of medical treatment on long-term survival of patients with heart failure after implantable cardioverter defibrillator and cardiac resynchronization device implantation (from the french national EGB database). Am J Cardiol. 2018;121(6):725–730.29402420
   PubMed Web of Science ®Google Scholar
• Witt CT, Kronborg MB, Nohr EA, et al. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival. Eur Heart J Cardiovasc Pharmacother. 2015;1(3):182–188.27533993
   PubMed Web of Science ®Google Scholar
• Nabeta T, Inomata T, Iida Y, et al. Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management. Heart Vessels. 2016;31(7):1109–1116.26253941
   PubMed Web of Science ®Google Scholar